BIOMAT Database Logo BIOMAT Database Logo

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test. 2021

Raoel Maan, and Milan J Sonneveld
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019168 Portasystemic Shunt, Transjugular Intrahepatic A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30) Portosystemic Shunt, Transjugular Intrahepatic,TIPS,TIPSS,Shunt, Transjugular Intrahepatic Portasystemic,Shunt, Transjugular Intrahepatic Portosystemic,Transjugular Intrahepatic Portasystemic Shunt

Related Publications

Raoel Maan, and Milan J Sonneveld
Editorial: stratifying risk of adverse outcomes in cirrhosis-the Hepquant SHUNT test. Authors' reply.
April 2021, Alimentary pharmacology & therapeutics,
Raoel Maan, and Milan J Sonneveld
Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test.
April 2021, Alimentary pharmacology & therapeutics,
Raoel Maan, and Milan J Sonneveld
Compartmental model describing the physiological basis for the HepQuant SHUNT test.
February 2023, Translational research : the journal of laboratory and clinical medicine,
Raoel Maan, and Milan J Sonneveld
Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
November 2019, Congenital heart disease,
Raoel Maan, and Milan J Sonneveld
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test.
April 2024, Clinical and translational science,
Raoel Maan, and Milan J Sonneveld
The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.
July 2021, Translational research : the journal of laboratory and clinical medicine,
Raoel Maan, and Milan J Sonneveld
Editorial: Meaningfully Stratifying the Autism Spectra.
December 2020, Journal of the American Academy of Child and Adolescent Psychiatry,
Raoel Maan, and Milan J Sonneveld
HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.
April 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Raoel Maan, and Milan J Sonneveld
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test.
May 2023, Cancers,
Raoel Maan, and Milan J Sonneveld
Editorial: the polygenic risk of cirrhosis development.
April 2021, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!